3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Lymphoid
1
Conditions
Lymphoma
84
Lymphoma, Non-Hodgkin
82
Precursor Cell Lymphoblastic Leukemia-Lymphoma
79
Leukemia, Lymphocytic, Chronic, B-Cell
65
Lymphoma, Large B-Cell, Diffuse
49
Lymphoma, Follicular
49
Hodgkin Disease
39
Burkitt Lymphoma
38
Recurrence
35
Multiple Myeloma
33
Leukemia, Myeloid, Acute
32
Leukemia
32
Lymphoma, Mantle-Cell
30
Lymphoma, B-Cell
28
Neoplasms
22
Myelodysplastic Syndromes
22
Hematologic Neoplasms
21
Waldenstrom Macroglobulinemia
16
Lymphoma, B-Cell, Marginal Zone
16
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
14
Leukemia, B-Cell
14
Sarcoma
12
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
10
Lymphoma, T-Cell, Peripheral
10
Lymphoma, T-Cell
10
Lymphoma, Large-Cell, Anaplastic
10
Glioma
10
Osteosarcoma
9
Neuroblastoma
9
Mycosis Fungoides
9
Interventions
dolutegravir
1
Tenofovir
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
HTLV-I Infections
×
Lymphoid
×
30 days
×
Clear all
NCT07555431
2026-06-02
DOT-H
Fundação Bahiana de Infectologia
Phase 2
Recruiting
146 enrolled